Prelude Capital Management, LLC Adverum Biotechnologies, Inc. Transaction History

Prelude Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$9.84 - $14.26 $72,816 - $105,524	-7,400 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$10.3 - $21.64 $76,220 - $160,136	7,400 New	7,400 $76,000
Q2 2018 Aug 14, 2018	SELL	$5.3 - $6.9 $21,200 - $27,600	-4,000 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$3.65 - $7.95 $14,600 - $31,800	4,000 New	4,000 $23,000

2.53M

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $718M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.